Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer

Lung

Volumn 183, Issue 1, 2005, Pages 43-52

  Dudek, Arkadiusz Z ^a,d   Leśniewski Kmak, Krzysztof ^b   Bliss, Robin L ^c   Brunstein, Claudio ^a   Condon, Debra L ^a   Kratzke, Robert A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Gemcitabine; Relapsed; Small cell lung cancer; Vinorelbine

Indexed keywords

GEMCITABINE; NAVELBINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; VINBLASTINE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DRUG ACTIVITY; DRUG SCREENING; FATIGUE; FEMALE; FOLLOW UP; HEARING LOSS; HEMATOLOGIC DISEASE; HUMAN; INFECTION; LUNG SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; WEIGHT REDUCTION; DOSE RESPONSE; DRUG ADMINISTRATION; LUNG TUMOR; MIDDLE AGED; MORTALITY; PILOT STUDY; SMALL CELL CARCINOMA; SURVIVAL; TIME; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; SURVIVAL ANALYSIS; TIME FACTORS; VINBLASTINE;

EID: 19844366119     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-004-2524-1     Document Type: Article

References (29)

1. CG Chute ER Greenberg J Baron 1985 Presenting conditions of 1,539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont Cancer 56 2107 2111
2. SH Landes T Murray S Bodden 1999 Cancer statistics CA Cancer J Clin 49 8
3. VTJ de Vita S Hellman SA Rosenberg 2001 Cancer: Principles and Practice of Oncology, 6th ed J. B. Lippincott Philadelphia, PA
4. DM Parkin R Sankaranarayanan 1994 Overview on small cell lung cancer in the world: industrialized countries, Third World, Eastern Europe Anticancer Res 14 1B 277 282
5. A Argiris J Murren 2001 Staging and prognosis of small cell lung cancer Cancer 5 437 447
6. WK Evans R Feld D Osoba 1984 VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer Cancer 53 7 1461 1466
7. WK Evans D Osoba R Feld 1985 Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer J Clin Oncol 3 1 65 71
8. WK Evans FA Shepherd R Feld 1985 VP-16 and cisplatin as first-line therapy for small-cell lung cancer J Clin Oncol 3 11 1471 1477
9. RB Livingstone TN Moore L Heilbrun 1978 Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study Ann Intern Med 88 194 199
10. BJ Roth DH Johnson LH Einhorn 1992 Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive stage small-cell lung cancer: a phase III trial of the Southern Cancer Study Group J Clin Oncol 10 282 291
11. FA Shepherd WK Evans R MacCormick 1987 Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer Cancer Treat Rep 71 10 941 944
12. J Von Pawel JH Schiller FA Shepherd 1999 Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer J Clin Oncol 17 2 658 667
13. N Masuda M Fukuoka Y Kusunoki 1992 CPT-11-:a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer J Clin Oncol 10 8 1225 1229
14. S Kakolyris D Mavroudis N Tsavaris 2001 Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study Ann Oncol 12 2 193 197
15. E Samantas H Kalofonos H Linardou 2000 Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study Ann Oncol 11 11 1395 1397
16. M Ichiki R Gohara T Rikimaru 2003 Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study Chemomerapy 49 4 200 205
17. I van der Lee EF Smit JWG van Putten 2001 Single-agent gemcitabine in patients with resistant small-cell lung cancer Ann Oncol 12 4 557 561
18. GA Masters L Declerck C Blanke 2003 Eastern Cooperative Oncology Group. Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597 J Clin Oncol 21 8 1550 1555
19. Y Cormier E Eisenhauer A Muldal 1994 Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group Ann Oncol 5 3 283 285
20. DS Ettinger 2001 New drags for chemotherapy-naïve patients with extensive-disease small cell lung cancer Semin Oncol 28 suppl. 4 27 29
21. B Faderl J von Pawel 2001 Phase II trial of gemcitabine, carboplatin and vindesine in extensive disease stage I/II small cell lung cancer (ED I/II SCLC) Ann Oncol 11 Suppl 113
22. Marinis De Filippo Cortesi Enrico Paoluzzi Luca 2000 Cisplatin (P), etoposide (E) and gemcitabine (G) in untreated patients with small cell lung cancer (SCLC): results of a multi-institutional phase II trial of GOL (Oncological Group of Lazio) Ann Oncol 11 Suppl 111
23. J Jassem H Karnicka-Mlodkowska C van Pottelsberghe 1993 Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group Eur J Cancer 29A 12 1720 2
24. K Furuse K Kubota M Kawahara 1996 Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group Oncology 53 2 169 172
25. A Depierre T Le Chevalier E. Quoix 1997 Phase II trial of navelbine (NVB) in small cell lung cancer (SCLC) Lung Cancer 18 suppl. 1 3
26. C Gridelli F Perrone GP Ianniello 1998 Carboplatin plus vinorelbin, a new well-tolerated and active regimen for the treatment of extensive-stage small cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole J Clin Oncol 16 4 1414 1419
27. World Health Organization 1979 WHO Handbook for Reporting Results of Cancer Treatment WHO Offset Publication No. 48 Geneva
28. RS Herbst C Lynch M Vasconcelles 2001 Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of phase I trial Cancer Chemother Pharmacol 48 2 151 159
29. JD Hainsworth HA Burris 3rd JB Erland M Baker 2003 Minnie Pearl Cancer Research Network. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network Cancer Invest 21 2 193 199